Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial

K. Harrison, D. Vlahov, K. Jones, Karen Charron, M. L. Clements

Research output: Contribution to journalArticle

Abstract

Injection drug users (IDUs) at high risk for human immunodeficiency virus (HIV) infection are being identified as a population for HIV vaccine trials. We studied willingness of drug users to enroll and their comprehension of consent procedures in the context of a Phase II trial at one site. Of 175 people screened for enrollment and whose data sets were complete, 119 (68%) were IDUs. Of the 71 who were eligible, 39 (55%) were IDUs. Exclusion of IDUs was usually for medical reasons. Using a 17-item true/false test, comprehension of the informed consent procedure was high (median score, 16 of 17 for IDUs and non-IDUs); only three subjects (all of whom were IDUs) were excluded from enrollment due to lack of comprehension. Follow-up rates were similar for IDUs and non-IDUs. These data suggest that recruitment of IDUs into HIV vaccine trials is feasible, that IDUs can comprehend and complete the informed consent procedures, and that they return for follow-up visits.

Original languageEnglish (US)
Pages (from-to)386-390
Number of pages5
JournalJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume10
Issue number3
StatePublished - 1995

Fingerprint

Drug Users
Vaccines
HIV
Injections
Informed Consent
Virus Diseases

Keywords

  • HIV vaccine trials
  • human immunodeficiency virus
  • informed consent
  • substance abuse

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Virology

Cite this

Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. / Harrison, K.; Vlahov, D.; Jones, K.; Charron, Karen; Clements, M. L.

In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 10, No. 3, 1995, p. 386-390.

Research output: Contribution to journalArticle

@article{d4d12f80b24e4095b4ec479edf748a36,
title = "Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial",
abstract = "Injection drug users (IDUs) at high risk for human immunodeficiency virus (HIV) infection are being identified as a population for HIV vaccine trials. We studied willingness of drug users to enroll and their comprehension of consent procedures in the context of a Phase II trial at one site. Of 175 people screened for enrollment and whose data sets were complete, 119 (68{\%}) were IDUs. Of the 71 who were eligible, 39 (55{\%}) were IDUs. Exclusion of IDUs was usually for medical reasons. Using a 17-item true/false test, comprehension of the informed consent procedure was high (median score, 16 of 17 for IDUs and non-IDUs); only three subjects (all of whom were IDUs) were excluded from enrollment due to lack of comprehension. Follow-up rates were similar for IDUs and non-IDUs. These data suggest that recruitment of IDUs into HIV vaccine trials is feasible, that IDUs can comprehend and complete the informed consent procedures, and that they return for follow-up visits.",
keywords = "HIV vaccine trials, human immunodeficiency virus, informed consent, substance abuse",
author = "K. Harrison and D. Vlahov and K. Jones and Karen Charron and Clements, {M. L.}",
year = "1995",
language = "English (US)",
volume = "10",
pages = "386--390",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial

AU - Harrison, K.

AU - Vlahov, D.

AU - Jones, K.

AU - Charron, Karen

AU - Clements, M. L.

PY - 1995

Y1 - 1995

N2 - Injection drug users (IDUs) at high risk for human immunodeficiency virus (HIV) infection are being identified as a population for HIV vaccine trials. We studied willingness of drug users to enroll and their comprehension of consent procedures in the context of a Phase II trial at one site. Of 175 people screened for enrollment and whose data sets were complete, 119 (68%) were IDUs. Of the 71 who were eligible, 39 (55%) were IDUs. Exclusion of IDUs was usually for medical reasons. Using a 17-item true/false test, comprehension of the informed consent procedure was high (median score, 16 of 17 for IDUs and non-IDUs); only three subjects (all of whom were IDUs) were excluded from enrollment due to lack of comprehension. Follow-up rates were similar for IDUs and non-IDUs. These data suggest that recruitment of IDUs into HIV vaccine trials is feasible, that IDUs can comprehend and complete the informed consent procedures, and that they return for follow-up visits.

AB - Injection drug users (IDUs) at high risk for human immunodeficiency virus (HIV) infection are being identified as a population for HIV vaccine trials. We studied willingness of drug users to enroll and their comprehension of consent procedures in the context of a Phase II trial at one site. Of 175 people screened for enrollment and whose data sets were complete, 119 (68%) were IDUs. Of the 71 who were eligible, 39 (55%) were IDUs. Exclusion of IDUs was usually for medical reasons. Using a 17-item true/false test, comprehension of the informed consent procedure was high (median score, 16 of 17 for IDUs and non-IDUs); only three subjects (all of whom were IDUs) were excluded from enrollment due to lack of comprehension. Follow-up rates were similar for IDUs and non-IDUs. These data suggest that recruitment of IDUs into HIV vaccine trials is feasible, that IDUs can comprehend and complete the informed consent procedures, and that they return for follow-up visits.

KW - HIV vaccine trials

KW - human immunodeficiency virus

KW - informed consent

KW - substance abuse

UR - http://www.scopus.com/inward/record.url?scp=0028788544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028788544&partnerID=8YFLogxK

M3 - Article

C2 - 7552502

AN - SCOPUS:0028788544

VL - 10

SP - 386

EP - 390

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -